US Patent 7195879 Method for identifying modulators of NA
Patent 7195879 was granted and assigned to Ortho-McNeil Pharmaceutical on March, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Adrienne Dubin0
Edward Kaftan0
Sandra Chaplan0
Sean Brown0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+419 characters)
Article
Patent abstract
The present invention provides methods to manipulate differentiation of a neuroblastoma cell line (IMR-32) such that predominant Nav expression is either Nav1.3 in IMR-32 cells exposed to retinoic acid or Nav1.7 in cells grown under non-differentiating conditions. The cells of the present invention are useful for the discovery of new compounds that modulate the function of either Nav1.3 and/or Nav1.7.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07195879 Method for identifying modulators of NA US Patent 7195879 Method for identifying modulators of NA
Infobox
Patent Number
071958790
Patent Number
71958790
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071958790
Date of Patent
March 27, 2007
0Patent Application Number
101217590
Date Filed
April 12, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07195879 Method for identifying modulators of NA
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07195879
Date of patent
March 27, 2007
Patent application number
10121759
Date Filed
April 12, 2002
Patent primary examiner
Find more entities like US Patent 7195879 Method for identifying modulators of NA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.